As the spread of COVID-19 has placed pressure on healthcare resources, the FDA has issued an unprecedented amount of new guidance to give greater flexibility and relief to all parts of the healthcare system so as to better respond for the duration of the national emergency. HIDA has compiled recent guidance from the FDA on PPE, diagnostics and therapeutics.